This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

9-11 November 2021
Fiera MilanoMilan, Italy
Menu
Key Sessions
Judy Chou
KEYNOTE PRESENTATION: Today’s Challenges and Opportunities in Biomanufacturing
Bayer Pharmaceuticals
Parrish Galliher
KEYNOTE PRESENTATION: BioPharma Tomorrow: Rethinking Efficiency
GE Healthcare Life Sciences
keyboard_arrow_right

DAY ONE

keyboard_arrow_leftSearch & Filter
search

DAY ONE

search
09:30 - 10:3060 mins
Registration and Opening of CPhI worldwide Exhibition Halls
    10:30 - 13:50200 mins
    Bioproduction Main Opening Plenary Session
    The main Bioproduction conference will begin at 13:50 with the opening plenary talks. Attendees are welcome to attend the sessions taking place in the Bioproduction Theatre part of CPhI worldwide Exhibition prior to this start time.
      10:30 - 11:4070 mins
      Bioproduction Theatre part of CPhI worldwide Exhibition
      Training Workshop: An Introduction to Biopharmaceutical Processing, Current Strategies and Future Landscape
      • John Milne - Training Director, NIBRT
      11:50 - 12:2030 mins
      Bioproduction Theatre part of CPhI worldwide Exhibition
      Reinventing the CMO Client Experience: Case Studies in Adapting to the Industry and Client Needs
      • Richard Lee - Head of Drug Product Business Unit, Samsung BioLogics
      • Brad Larson - Executive Director, DP Account Management, Samsung BioLogics
      12:30 - 13:0030 mins
      Bioproduction Theatre part of CPhI worldwide Exhibition
      Adapting Manufacturing Strategies and Facilities to Next Generation Biotherapeutics and Emerging Therapies
      • Dave Wolton - Operations Consultant, PM Group
      13:10 - 13:4030 mins
      Bioproduction Theatre part of CPhI worldwide Exhibition
      Panel Discussion: Manufacturing and Commercialisation of Cell and Gene Therapies
      • Ohad Karnieli - President and Co-Founder, Atvio Biotech
      • Ian Dacey - Process Subject Mater Expert, PM Group
      13:50 - 14:0010 mins
      Bioproduction Main Opening Plenary Session
      Chairperson's Opening Remarks
      • Amir Goudarzi - Head Process Engineering Biologics Pilot Plant, UCB
      14:00 - 14:3030 mins
      Bioproduction Main Opening Plenary Session
      KEYNOTE PRESENTATION: Today’s Challenges and Opportunities in Biomanufacturing
      • Judy Chou - Senior Vice President & Global Head of Biotech; Site Head of Bayer Berkeley CA USA, Bayer Pharmaceuticals
      14:30 - 15:0030 mins
      Bioproduction Main Opening Plenary Session
      KEYNOTE PRESENTATION: BioPharma Tomorrow: Rethinking Efficiency
      • Parrish Galliher - CTO - Upstream, GE Healthcare Life Sciences
      15:00 - 15:3030 mins
      Afternoon Coffee Break & Networking
        15:30 - 16:0030 mins
        Cell Line Development
        High Speed Cell Line Development for Short Timelines to IND
        • David Kentner - Principal Scientist, Novartis
        15:30 - 16:0030 mins
        Upstream Processing & Cell Culture
        Continuous USP using HCD Perfusion and Alternating Bioreactors
        • Ard Tijsterman, MSc - Chief Executive Officer, Biosana Pharma BV
        15:30 - 16:0030 mins
        Downstream Processing
        New Paradigm in ADC Polishing
        • Romas Skudas - Senior Manager, Merck KGaA
        15:30 - 16:0030 mins
        Manufacturing Strategies & Bioprocessing 4.0
        Learnings and Challenges in Industrialization of Late Stage Biopharmaceuticals
        • Amir Goudarzi - Head Process Engineering Biologics Pilot Plant, UCB
        15:30 - 16:0030 mins
        Bioanalytical & Formulation
        KEYNOTE: Deploying Appropriate Spending on Analytical Testing To Avoid Wasting Resources
        • Gerald Gellermann - Senior Fellow, Novartis Biologics
        16:00 - 16:3030 mins
        Cell Line Development
        Bispecific Molecule Formats and Concepts for Cell Line Development
        • Holger Richly - Head of Laboratory Biologicals Development / Molecular Biology, Boehringer Ingelheim Pharma GmbH & Co. KG
        16:00 - 16:3030 mins
        Upstream Processing & Cell Culture
        Comparison of Alternative Perfusion Systems for Intensified (N-1) Inoculum Generation
        • Steven Ruddock - Senior Research and Development Manager, BioPharmaceutical Development, Astra Zeneca
        16:00 - 16:3030 mins
        Downstream Processing
        Development and Implementation of a Harmonized Purification Platform for a Modern, Diverse Pipeline
        • Florian Capito, Sanofi-Aventis Deutschland GmbH
        16:00 - 16:3030 mins
        Manufacturing Strategies & Bioprocessing 4.0
        Driving Continuous Improvement with Large Scale Manufacturing
        • Ken Green, Ph.D - Head of Cell Culture Manufacturing, Samsung Biologics
        16:00 - 16:3030 mins
        Bioanalytical & Formulation
        A Case Study for Re-formulating a Commercial Monoclonal Antibody for New Therapeutic Applications
        • Lorène Bernasconi - Head of Analytical and Bioanalytical Development, Sobi
        16:30 - 17:0030 mins
        Cell Line Development
        Integrating Synthetic Biology Into Upstream Process Development
        • Adam Brown - Lecturer in DNA Engineering, University of Sheffield, UK
        16:30 - 17:0030 mins
        Upstream Processing & Cell Culture
        Media Development Combined With Frozen Process Intermediates For Intensified Seed Train Expansion
        • Luis Fernando Ayala Solares - Scientist, Life Science, Upstream R&D, Merck KGaA
        16:30 - 17:0030 mins
        Downstream Processing
        The Purification of Influenza A Virus Subtype H1N1 Using New Ion Exchanger
        • Wei Zhang - Associate Staff Scientist, Downstream Processing Group, Bioprocessing Technology Institute of Singapore, A*STAR
        16:30 - 17:0030 mins
        Manufacturing Strategies & Bioprocessing 4.0
        Monoclonal Antibody Disulfide Bond Reduction In Clinical Manufacturing and Mitigation using Copper Sulfate: A Case Study
        • Sanjay Nilapwar, Ph.D. - Senior Research Investigator (Purification Development), Incyte Corporation
        16:30 - 17:0030 mins
        Bioanalytical & Formulation
        Risk Assessments Based On Immunogenicity Assays
        • Harry Yang - Senior Director, Medimmune, USA
        17:00 - 17:3030 mins
        Cell Line Development
        Smart Strategies to Enhance Productivity, Improve Titers, Cell Culture Performance and Product Quality.
        • Florian M. Wurm - Professor Emeritus, Swiss Federal Institute of Technology Lausanne (EPFL)
        17:00 - 17:3030 mins
        Upstream Processing & Cell Culture
        Building Quality and Consistency into Bioproduction Media and Supplements
        • Stacy Holdread - Manager, Research & Development, Thermo Fisher Scientific
        17:00 - 17:3030 mins
        Downstream Processing
        Continuous Bioprocessing –The Alignment of Future Strategies to Industry 4.0
        • Peter Levison, Ph.D. - Executive Director Business Development, Pall Life Sciences
        17:00 - 17:3030 mins
        Manufacturing Strategies & Bioprocessing 4.0
        Design Considerations Towards an Intensified Single-Use Facility
        • Gerben Zijlstra - Global Technology Consultant, Continuous & Intensified Biomanufacturing, Sartorius Stedim Biotech
        17:00 - 17:3030 mins
        Bioanalytical & Formulation
        Introducing QbD in the Production of a Biologic Drug- Multiple Attribute Methodology and Host Cell Protein analysis
        • Christian Baumann - Biologics Workflow Specialist, Sciex Germany
        17:30 - 18:0030 mins
        End of Day One
          NextDAY TWO
          Filter
          Streams
          Formats
          Choose Day